International Patent: PROBIOTIC INTERVENTION METHOD BASED ON BASELINE ABUNDANCE OF INTESTINAL MICROBIOTA

GENEVA, July 31 -- SHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES filed a patent application (CN2025/075538) for “PROBIOTIC INTERVENTION METHOD BASED ON BASELINE ABUNDANCE OF INTESTINAL MICROBIOTA”. With publication no. WO/2026/156902, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 35/741

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....